Skip to content
Screener

Amgen AMGN Q1 2026 earnings

Reported April 30, 2026 · After market close

Revenue$8.6BBeat by $42.9M
EPS$5.15Beat by $0.38
Revenue estimate$8.6B
EPS estimate$4.77
“Our first quarter results demonstrate the strength of our business, with 16 brands achieving double-digit growth, enabling us to grow through expected patent expirations and increased competition. With a new wave of molecules progressing in Phase 3 clinical development, we're confident in our ability to deliver attractive long-term growth,”
Robert A. Bradway

Next report

Nov 3, 2026 (in a month)
Revenue estimate$10.0B
EPS estimate$5.78

Financials

Q1 2026

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$189.67B+13.3%
Enterprise value$246.43B+9.9%
P/E24.3×-3.9×
P/S5.1×+0.2×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Segments

By product

See full
Other products$1.5B+3.6%
Repatha$876.0M+16.2%
Prolia$727.0M-33.8%
EVENITY$562.0M+27.1%
TEPEZZA$490.0M+28.6%

By segment

See full
Reportable Segment$8.6B+5.8%

FAQ

When did Amgen report Q1 2026 earnings?
Amgen (AMGN) reported Q1 2026 earnings on April 30, 2026 after market close.
What were Amgen's Q1 2026 revenue and EPS?
Amgen reported revenue of $8.6B and eps of $5.15 for Q1 2026.
Did Amgen beat estimates in Q1 2026?
Revenue beat the consensus estimate of $8.6B by $42.9M. EPS beat the consensus estimate of $4.77 by $0.38.
How did Amgen's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.8% from $8.1B a year earlier and eps grew 5.1% from $4.90.
Where can I find Amgen's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000318154-26-000054) and the 10-Q periodic report (0000318154-26-000057) directly on SEC EDGAR. The filing index links above go to sec.gov.